McIntyre says he gets asked about this worldwide and shares a summary of the mechanistic data on GLP-1 drugs and loss of pleasure.
Recap by typeshit. Post by Roger S. McIntyre, MD, FRCPC on X.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
The protective effect showed up even at doses too low to cause meaningful weight loss, according to the Cedars-Sinai-led laboratory research.
Research suggests some people on weight loss pills or injections may be paying more than they need to, and users are being told to shop around.
Loading…